If you receive a denial letter from your insurer, don’t appeal the decision before seeking legal advice, says a leading ...

The current model for managing chronic obstructive pulmonary disease (COPD) generally considers inhalers from the same therapeutic class to be clinically equivalent.1 When a long-acting muscarinic ...

Research reveals GLP-1 and SGLT-2 medications may lower COPD exacerbation risk in diabetes, offering new hope for dual condition management.

Share on Pinterest GLP-1 and SGLT-2 drugs may be the best treatments for people ... are treated with GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than those ...

We recently published a list of 12 Best Growth Stocks to Invest In According to Analysts. In this article, we are going to ...

Here are the steps experts say you can take to stay safe if you are at increased risk.

The NHS is urging thousands of people to cut down on their intake of tea and coffee due to an uncomfortable side effect ...

The hospital is the only state facility listed among top performers in the U.S. on Healthgrades national rankings.

After that technology had proven its worth, the full-blown virtual hospital was launched by the Saudi ministry of health in ...

GSK (GSK) announced that the China National Medical Products Administration, CNMPA, has accepted for review the new drug application for the ...

St. Vincent’s Riverside is now offering a breakthrough treatment for patients diagnosed with chronic pulmonary obstructive disease (COPD)/emphysema.>>> STREAM ACTION NEWS JAX LIVE [DOWNLOAD: Free ...